Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray

[1]  C. Palmeira,et al.  miR-378a: a new emerging microRNA in metabolism , 2019, Cellular and Molecular Life Sciences.

[2]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2019 , 2018, Nucleic Acids Res..

[3]  D. Trégouët,et al.  Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Kai Xue,et al.  Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome , 2018, Journal of cellular biochemistry.

[5]  H. Escobar-Morreale.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment , 2018, Nature Reviews Endocrinology.

[6]  W. Garvey,et al.  Improved systemic metabolism and adipocyte biology in miR-150 knockout mice , 2018, Metabolism: clinical and experimental.

[7]  A. Vidal-Puig,et al.  Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome. , 2017, Advances in experimental medicine and biology.

[8]  Deng Pan,et al.  DGIdb 2.0: mining clinically relevant drug–gene interactions , 2015, Nucleic Acids Res..

[9]  L. An,et al.  Low-density lipoprotein receptor affects the fertility of female mice. , 2015, Reproduction, fertility, and development.

[10]  H. Dweep,et al.  miRWalk2.0: a comprehensive atlas of microRNA-target interactions , 2015, Nature Methods.

[11]  J. Dominguez,et al.  Renal C3 Complement Component: Feed Forward to Diabetic Kidney Disease , 2015, American Journal of Nephrology.

[12]  Wei Zhang,et al.  Characterization of microRNA expression in serous ovarian carcinoma. , 2014, International journal of molecular medicine.

[13]  G. Valacchi,et al.  Genes Related to Mitochondrial Functions, Protein Degradation, and Chromatin Folding Are Differentially Expressed in Lymphomonocytes of Rett Syndrome Patients , 2013, Mediators of inflammation.

[14]  A. Baranova,et al.  Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS) , 2013, Journal of Translational Medicine.

[15]  P. Kellman,et al.  MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study , 2012, Journal of Cardiovascular Magnetic Resonance.

[16]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[17]  Harsh Dweep,et al.  A miR-1207-5p Binding Site Polymorphism Abolishes Regulation of HBEGF and Is Associated with Disease Severity in CFHR5 Nephropathy , 2012, PloS one.

[18]  Enrico Carmina,et al.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. , 2012, Fertility and sterility.

[19]  P. Arck,et al.  Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS). , 2011, Journal of reproductive immunology.

[20]  Ricardo Azziz,et al.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis , 2011, Nature Reviews Endocrinology.

[21]  A. Fulghesu,et al.  Il-6 Serum Levels and Production Is Related to an Altered Immune Response in Polycystic Ovary Syndrome Girls with Insulin Resistance , 2011, Mediators of inflammation.

[22]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[23]  R. Azziz,et al.  Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. , 2010, The Journal of clinical endocrinology and metabolism.

[24]  A. López-Bermejo,et al.  Low body adiposity and high leptinemia in breast-fed infants born small-for-gestational-age. , 2010, The Journal of pediatrics.

[25]  R. Azziz,et al.  Impact of obesity on the risk for polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[26]  G. Di Fede,et al.  Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. , 2007, The Journal of clinical endocrinology and metabolism.

[27]  E. Bixler,et al.  Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. , 2006, Metabolism: clinical and experimental.

[28]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .

[29]  Hsin-Shih Wang,et al.  Polycystic ovary syndrome (PCOS), insulin resistance and insulin-like growth factors (IGfs)/IGF-binding proteins (IGFBPs). , 2003, Chang Gung medical journal.

[30]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[31]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[32]  T. Ciaraldi,et al.  Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. , 2000, Journal of pediatric endocrinology & metabolism : JPEM.

[33]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[34]  J. Olefsky,et al.  Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. , 1992, The Journal of clinical endocrinology and metabolism.